Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 15 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND POTASSIUM CHLORIDE 0 15 IN PLASTIC CONTAINER.
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER vs DEXTROSE 5% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Dextrose 5% provides a source of calories and water for hydration, and potassium chloride replenishes potassium stores to maintain cellular function and electrolyte balance.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
Intravenous infusion; rate and volume determined by fluid, electrolyte, and caloric requirements of the patient. Typical adult dose: 500-1000 mL of D5 0.15% KCl at a rate of 100-200 mL/hour (2 mL/kg/hour maximum in normokalemic patients). Monitor serum potassium and glucose.
None Documented
None Documented
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
Exogenous potassium has a half-life of approximately 8 hours; dextrose has a half-life of minutes (continuous utilization). Context: Potassium half-life is prolonged in renal failure, requiring dose adjustment.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Potassium is eliminated primarily by the kidneys (90%), with minor fecal loss (10%). Dextrose is metabolized to CO2 and water; excess is excreted renally. In renal impairment, potassium excretion is reduced.
Category C
Category C
IV Fluid
IV Fluid